XML 35 R6.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Cash flows from operating activities:    
Net income $ 39,034 $ 32,648
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 27,716 26,495
Non-cash lease expense 2,267 1,939
Amortization of marketing contract intangible 0 1,803
Amortization of deferred revenue (830) (572)
Amortization of deferred financing costs and debt discount 1,283 1,250
Income from equity method investments (10,150) (8,490)
Dividends from equity method investments 7,338 9,509
Loss on extinguishment of debt 0 3,571
Other non-cash adjustments (3,028) 1,492
Changes in assets and liabilities:    
Accounts receivable 2,508 (15,862)
Inventories and other current assets 232 670
Accounts payable and other current liabilities (17,579) (2,359)
Accounts receivable/payable to related parties (21,158) (8,145)
Net investment in leases - affiliate 5,161 0
Non-current assets and liabilities, net (1,244) (91)
Net cash provided by operating activities 31,550 43,858
Cash flows from investing activities:    
Purchases of property, plant and equipment (55,474) (11,255)
Proceeds from sales of property, plant and equipment 4,318 42
Purchases of intangible assets (4,558) (781)
Business combination, net of cash acquired (181,180) 0
Distributions from equity method investments 2,127 2,133
Net cash used in investing activities (234,767) (9,861)
Cash flows from financing activities:    
Distributions to common unitholders - public (21,609) (10,012)
Distributions to common unitholders - Delek Holdings (37,693) (36,198)
Proceeds from term debt 0 650,000
Payments on term debt 0 (531,250)
Proceeds from revolving facility 598,500 184,900
Payments on revolving facility (328,800) (400,200)
Unit repurchase (10,000) 0
Proceeds from issuance of common units, net of underwriters' discount 0 132,327
Payments on other financing agreements 0 (6,214)
Deferred financing costs paid 0 (10,946)
Other financing activities (458) (487)
Net cash provided by (used in) financing activities 199,940 (28,080)
Net (decrease) increase in cash and cash equivalents (3,277) 5,917
Cash and cash equivalents at the beginning of the period 5,384 3,755
Cash and cash equivalents at the end of the period 2,107 9,672
Cash paid during the period for:    
Interest 54,623 28,503
Non-cash investing activities:    
Common units issued in connection with Gravity Acquisition 91,511 0
Increase in accrued capital expenditures 16,469 3,910
Non-cash financing activities:    
Non-cash lease liability arising from obtaining right of use assets during the period $ 9,447 $ 537